Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Asset Utilization Ratio (2020 - 2023)

Historic Asset Utilization Ratio for ADC Therapeutics (ADCT) over the last 4 years, with Q3 2023 value amounting to 143.4.

  • ADC Therapeutics' Asset Utilization Ratio rose 5374686.38% to 143.4 in Q3 2023 from the same period last year, while for Sep 2023 it was 143.4, marking a year-over-year increase of 5374686.38%. This contributed to the annual value of 0.0 for FY2022, which is N/A changed from last year.
  • Latest data reveals that ADC Therapeutics reported Asset Utilization Ratio of 143.4 as of Q3 2023, which was up 5374686.38% from 143.41 recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Asset Utilization Ratio registered a high of 145.87 during Q1 2023, and its lowest value of 0.0 during Q1 2021.
  • For the 4-year period, ADC Therapeutics' Asset Utilization Ratio averaged around 47.52, with its median value being 0.19 (2022).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 9794.15% in 2021, then surged by 205419401.31% in 2022.
  • Over the past 4 years, ADC Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.33 in 2020, then tumbled by 97.99% to 0.01 in 2021, then soared by 2054194.01% to 136.78 in 2022, then increased by 4.84% to 143.4 in 2023.
  • Its last three reported values are 143.4 in Q3 2023, 143.41 for Q2 2023, and 145.87 during Q1 2023.